The present invention provides a cannabis-based flavonoid pharmaceutical composition including any one or more selected from the group of Apigenin, Cannflavin A, Cannflavin B, Cannflavin C, Chiysoeriol, Cosmosiin and Flavocannabiside or their synthases, for the prevention and treatment of certain ocular diseases and related disorders.

Lowe; Henry I C

Toyang; Ngeh J.

Therapeutic agents containing cannabis flavonoid derivative for ocular disorders

The present invention provides a cannabis-based flavonoid pharmaceutical composition including any one or more selected from the group of Apigenin, Cannflavin A, Cannflavin B, Cannflavin C, Chrysoeriol, Cosmosiin and Flavocannabiside or their synthases, for the prevention and treatment of certain ocular diseases and related disorders.

Toyang; Ngeh J

A method of extracting cannabinoids, cannflavins, and/or essential oils from hemp and/or of producing a whole hemp extract lacking .DELTA..sup.9 -THC is herein described. The industrial hemp is harvested and the chaff is threshed from the seeds. The chaff is then ground and the ground chaff is extracted with an organic solvent. The extract is then loaded onto a chromatographic column selected to fractionate specific cannabinoids, cannflavins, and essential oils. In one embodiment, .DELTA..sup.9 -THC is fractionated out of the extract, producing a whole hemp extract lacking .DELTA..sup.9 -THC. In other embodiments, specific cannabinoids and related compounds of interest are fractionated out, thereby producing purified cannabinoids, cannflavins, and related compounds.

cannflavin/アサ属

Therapeutic agents containing cannabis flavonoid derivative for ocular disorders

Therapeutic agents containing cannabis flavonoid derivative for ocular disorders

Cannabinoid extraction method

科学に裏打ちされた最も完全な薬草データベース